Dense breast – an important clinical problem in menopausal management

Tomasz Pertyński; Grzegorz Stachowiak; Tomasz Stetkiewicz

Abstract

2/2005 vol. 4

Dense breast – an important clinical problem in menopausal management

Tomasz Pertyński

,

Grzegorz Stachowiak

,

Tomasz Stetkiewicz

Prz Menopauz 2005; 2: 38–43

Online publish date: 2005/04/14

View full text

AMA

Pertyński T, Stachowiak G, Stetkiewicz T. Dense breast – an important clinical problem in menopausal management. Menopause Review/Przegląd Menopauzalny. 2005;4(2):38-43.

APA

Pertyński, T., Stachowiak, G., & Stetkiewicz, T. (2005). Dense breast – an important clinical problem in menopausal management. Menopause Review/Przegląd Menopauzalny, 4(2), 38-43.

Chicago

Pertyński, Tomasz, Grzegorz Stachowiak, and Tomasz Stetkiewicz. 2005. "Dense breast – an important clinical problem in menopausal management". Menopause Review/Przegląd Menopauzalny 4 (2): 38-43.

Harvard

Pertyński, T., Stachowiak, G., and Stetkiewicz, T. (2005). Dense breast – an important clinical problem in menopausal management. Menopause Review/Przegląd Menopauzalny, 4(2), pp.38-43.

MLA

Pertyński, Tomasz et al. "Dense breast – an important clinical problem in menopausal management." Menopause Review/Przegląd Menopauzalny, vol. 4, no. 2, 2005, pp. 38-43.

Vancouver

Pertyński T, Stachowiak G, Stetkiewicz T. Dense breast – an important clinical problem in menopausal management. Menopause Review/Przegląd Menopauzalny. 2005;4(2):38-43.

There is an increased oncological risk in menopausal period and breast cancer is the most prevalent female neoplasm. Enhanced mammographic breast density (MBD) of menopausal women is relevant to breast cancer risk and can also appear during hormonal therapy (HT). In relation to MBD and breast cancer risk, menopausal HT should be based on low estradiol doses, SEEM progestins as well as tibolone.